Hyogo, Japan

Hideki Yamamura

This inventor holds 1 USPTO granted patent. Top assignee: Biofermin Pharmaceutical Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Yamamura. Retrieved from https://idiyas.com/inventor/hideki-yamamura-e48ipgsa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideki Yamamura

Introduction

Hideki Yamamura is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of enhancers for hypoglycemic effects. His work is characterized by a focus on improving the efficacy of existing treatments through innovative approaches.

Latest Patents

Yamamura holds a patent for a hypoglycemic effect enhancer. This invention enhances the activity of an α-glucosidase inhibitor and comprises at least one kind of bacteria selected from a group that includes bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria. This patent represents a significant advancement in the management of blood sugar levels.

Career Highlights

Yamamura is currently associated with Biofermin Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Yamamura collaborates with esteemed colleagues, including Yasuhiro Isa and Masaki Shimakawa. Their combined expertise fosters a productive environment for innovation and development.

Conclusion

Hideki Yamamura's contributions to the field of pharmaceuticals, particularly through his patent for a hypoglycemic effect enhancer, highlight his role as an influential inventor. His ongoing work at Biofermin Pharmaceutical Co., Ltd. continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…